2024 ASCO Direct™ Denver

Learn How to Claim Your Credit

 
 

Click here to view on-demand content!

Total Health's 2024 ASCO Direct™ Denver Conference is an officially licensed  ASCO Direct meeting. This Post ASCO Review showcases abstracts from highly rated presentations, allowing attendees to engage with the latest research and strategies in oncology education. This accredited meeting will be hosted as an in-person conference with on-demand access for registered attendees.

Event Page

 

Accreditation Information | 7.25

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 
  • Amedco LLC designates this activity for a maximum of 7.25 ANCC contact hours.

  • Amedco LLC designates this live activity for a maximum of 7.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Amedco LLC designates this activity for a maximum of 7.25 knowledge-based CPE contact hours.

    NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.

  • Learner Notification

    Objectives - After Attending This Program You Should Be Able To

    1. Integrate new evidence into everyday clinical practice, thereby improving the quality of care being delivered to patients living with and beyond cancer.

    2. Implement practice changes in a variety of treatment options for solid tumors, including lung, breast, melanoma, colorectal, non-colorectal GI, and GU cancers.

    3. Stimulate innovative strategies for new and additional research related to treatment and prevention.

    Disclosure of Conflict of Interest

    The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5)

    All individuals in a position to control the content of CE are listed below.

    Name Commercial Interest:Relationship

    John Burke

    Abbvie, Adaptive Biotechnologies, ADC Therapeutics, AstraZeneca , BeiGene,

    Bristol Myer Squibb, Constellation, Eli Lilly, Epizyme, Foresight,

    Genentech:Consultant

    BeiGene:Speakers Bureau

    Genmab - Consultancy Kura - Consultancy Kymera - Consultancy Morphosys -

    Consultancy, Research Funding Novartis - Consultancy Nurix - Consultancy

    Regeneron - Consultancy SeaGen - Consultancy TG Therapeutics - Consultancy

    Anthony Elias NA

    Laura Graham NA

    Andrew Kent NA

    Jennifer Klemp

    Caris Life Sciences, Inc:Employee

    Pfizer:Speakers Bureau

    Michael Lattanzi

    Merck, Aveo, Johnson & Johnson, Aadi, Pfizer:Consultant

    Pfizer, Aveo, Astrazeneca, EMD Serono, Pfizer, Merck, Johnson &

    Johnson:Speakers Bureau

    Mark Lewis

    AstraZeneca/Daiichi Sankyo, Astellas:Speakers Bureau

    TerSera:Consultant

    Vicki Mackie NA

    Reshma L. Mahtani

    Agendia, Astra Zeneca, Amgen, Daiichi Sankyo, Eisai, Gilead, Genentech, Hologic,

    Lilly, Merck, Novartis, Pfizer:Consultant

    Sami Mansfield NA

    Jeffrey Matous

    no others:Other

    BeiGene:Scientific/Medical Advisory Board Member

    Jessica McDermott NA

    Ravi Salgia NA

    Erin Schenk

    OncLive, Medscape:Speakers Bureau

    CDR-Life, Boehringer Ingelheim, Ideology Health, Harpoon, Takeda, Thetis

    Pharmaceuticals, Janssen:Scientific/Medical Advisory Board Member

    WC Communications, Thirdbridge, Slingshot Insights:Consultant

    Heloisa Soares

    Ipsen, Novartis, Exelixis:Consultant

    ITM:Other

    Ryan Weight NA

    Reyna Wilhelm NA

    Justin Kaiser NA

 
 

How to Get Your Certificate

  1. Go to thc.cmecertificateonline.com

  2. Click on the ASCO Denver 2024 link.

  3. For ABIM MOC click on the ASCO Denver 2024 ABIM MOC link.

  4. Evaluate the meeting.

  5. Print, download, or save your certificate for your records.

  6. If you lose your certificate, or need help, go to help.cmecertificateonline.com

 
 
Previous
Previous

2024 ASCO Direct™ Kansas City

Next
Next

2024 ASCO Direct™ Charlotte